Andrew J. Einhorn - Chief Financial Officer at RVL Pharmaceuticals plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
RVLP
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew J. Einhorn since 10 Feb 2025

Holdings reported by Andrew J. Einhorn for RVL Pharmaceuticals plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 141,473 $4,414 $0.0312 24 Jan 2022 Direct
Ordinary Shares 22,852 $713 $0.0312 24 Jan 2022 By family limited liability company
Share Option (Right to Buy) 249,814 04 Nov 2021 Direct Ordinary Shares

Transactions reported by Andrew J. Einhorn for RVL Pharmaceuticals plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.